Benefits (Research Focus) Multi-pathway research studied for paired investigation across four distinct peptide signaling pathways in a single research blend Tissue repair pathways investigated via BPC-157 and TB-500 components for angiogenesis and fibroblast migration endpoints Copper-peptide research explored via GHK-Cu for fibroblast activation, collagen synthesis, and dermal matrix remodeling Anti-inflammatory signaling examined via KPV (-MSHderived tripeptide) for NF-B pathway and inflammatory cytokine modulation Comparative pharmacology researched for paired vs single-compound endpoint differences across tissue repair, dermal, and inflammation models What Researchers Look At Fibroblast activation, collagen Type I/III synthesis, and dermal matrix protein expression Angiogenesis markers (VEGF, integrins) and endothelial cell migration assays NF-B pathway activity and inflammatory cytokine (TNF-, IL-6) modulation Wound closure rates and dermal repair endpoints in preclinical models Multi-component blend pharmacology versus single-peptide administration Quick Specs Form: Lyophilized white-to-blue powder (color from GHK-Cu copper complex) BPC-157: [add mg per COA] TB-500: [add mg per COA] GHK-Cu: [add mg per COA] KPV: [add mg per COA] Total Peptide Content: [80 mg or 100 mg per vial confirm against COA] Quantity: 1 vial Appearance: Pale blue to white lyophilizate Reconstitution: Bacteriostatic or sterile water (added by the end researcher) Purity: 99% by HPLC (per component) Identity: MS-verified (per COA) Storage: Protect from light Identity Basics Compound 1: BPC-157 (Body Protection Compound-157) Class: Synthetic pentadecapeptide
Ingredient transparency gap: A full Supplement Facts panel with per-ingredient dosages was not publicly posted on the brand's site at review time
Our findings indicate that FOXO4-DRI promotes apoptosis in senescent cells by disrupting the FOXO4-P53 interaction, thereby releasing and phosphorylating P53, which then translocates to the cytoplasm
Instead of sourcing multiple products separately, researchers can explore bpc 157 and tb 500 in one convenient combination, helping improve consistency and reduce unnecessary complexity
